Literature DB >> 17623958

A comparative study of intravenous patient-controlled analgesia morphine and tramadol in patients undergoing major operation.

M A Hadi1, H Shamsul Kamaruljan, A Saedah, N M Nik Abdullah.   

Abstract

The success of major surgery depends partly on providing effective post-operative pain relief, which can be commonly achieved by morphine administration via patient- controlled analgesic (PCA) system. Alternatively, tramadol which is a weak opioid analgesic, can be used for post operative pain relief. The purpose of this study was to evaluate the effectiveness of intravenous PCA tramadol in comparison with PCA morphine in term of analgesic properties, sedation and side effects. A randomized, double-blinded study was conducted on 160 ASA I and II patients who underwent major operations. Eighty of them received a loading dose of intravenous morphine 0.1 mg/kg followed by PCA morphine bolus of 1 mg (1 mg/ml) as required, while the other 80 patients received a loading dose of 2.5 mg/kg of intravenous tramadol followed by PCA infusion of 10 mg (10 mg/ml) as required. Patients were monitored for pain, sedation and side effects as well as respiratory rate, nausea, vomiting, pruritus, blood pressure and pulse rate. Patients were evaluated 30 minutes, 4 hours, 24 hours and 48 hours post operation. There were no differences in the demographic data between the two groups (p > 0.05). The overall mean pain score in tramadol group was 0.70 +/- 0.60 as compared to 0.75 +/- 0.67 for morphine group. The mean pain score for tramadol and morphine groups at 30 minutes, 4 hours, 24 hours and 48 hours post operation were 1.32 +/- 0.79, 104 +/- 0.79, 0.35 +/- 0.48, 0.09 +/- 0.33 and 1.35 +/- 0.99, 1.14 +/- 0.81, 0.40 +/- 0.54, 0.10 +/- 0.34 respectively. The overall mean sedation score in tramadol and morphine group was 0.39 +/- 0.44 as compared to 0.35 +/- 0.43 for morphine group. The mean sedation score for tramadol and morphine group at 30 minutes, 4 hours, 24 hours and 48 hours post operation were 0.90 +/- 0.74, 0.56 +/- 0.59, 0.075 +/- 0.27, 0.025 +/- 0.16 and 0.84 +/- 0.70, 0.46 +/- 0.64, 0.08 +/- 0.27, 0.01 +/- 0.11 respectively. There was no significant difference in the overall mean pain and sedation score between the two groups as well as for each duration assessed (p > 0.05). There were also no significant differences between the two groups with regard to the blood pressure and heart rate. The incidence of nausea, vomiting and pruritus were the same in the two groups. This study indicates that PCA tramadol is as equally effective as PCA morphine control following major surgery. The incidences of sedation, nausea or pruritus were the same in the two groups.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17623958

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  8 in total

Review 1.  Nausea and vomiting after surgery under general anesthesia: an evidence-based review concerning risk assessment, prevention, and treatment.

Authors:  Dirk Rüsch; Leopold H J Eberhart; Jan Wallenborn; Peter Kranke
Journal:  Dtsch Arztebl Int       Date:  2010-10-22       Impact factor: 5.594

2.  Intermittent tramadol vs tramadol administration via patient-controlled pump after lumbar discectomy: a randomized controlled trial.

Authors:  Biljana Kurtović; Krešimir Rotim; Tomislav Sajko; Cecilija Rotim; Adriano Friganović; Milan Milošević
Journal:  Croat Med J       Date:  2022-04-30       Impact factor: 2.415

3.  Morphine use in cancer surgery.

Authors:  Banafsheh Afsharimani; Peter J Cabot; Marie-Odile Parat
Journal:  Front Pharmacol       Date:  2011-08-08       Impact factor: 5.810

4.  Continuous Femoral Nerve Block versus Intravenous Patient Controlled Analgesia for Knee Mobility and Long-Term Pain in Patients Receiving Total Knee Replacement: A Randomized Controlled Trial.

Authors:  Lihua Peng; Li Ren; Peipei Qin; Jing Chen; Ping Feng; Haidan Lin; Min Su
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-28       Impact factor: 2.629

5.  Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial.

Authors:  Qianyu Zhuang; Yanyan Bian; Wei Wang; Jingmei Jiang; Bin Feng; Tiezheng Sun; Jianhao Lin; Miaofeng Zhang; Shigui Yan; Bin Shen; Fuxing Pei; Xisheng Weng
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

6.  Ramosetron Does Not Reduce the Analgesic Efficacy of Tramadol after Gynecological Laparoscopic Surgery.

Authors:  Yanghyun Kim; Sungwoo Kang
Journal:  Biomed Res Int       Date:  2019-07-09       Impact factor: 3.411

7.  Intravenous Tramadol is Effective in the Management of Postoperative Pain Following Abdominoplasty: A Three-Arm Randomized Placebo- and Active-Controlled Trial.

Authors:  Harold Minkowitz; Hernan Salazar; David Leiman; Daneshvari Solanki; Lucy Lu; Scott Reines; Michael Ryan; Mark Harnett; Neil Singla
Journal:  Drugs R D       Date:  2020-09

8.  Comparison of Patient-Controlled Analgesia With Tramadol or Morphine After Video-Assisted Thoracoscopic Surgery in Geriatric Patients.

Authors:  Gulay Ulger; Ramazan Baldemir
Journal:  Cureus       Date:  2021-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.